According to the Zhitong Finance App, Lizhu Pharmaceutical (01513.HK) announced results for the six months ended June 30, 2026. The group achieved operating income of about RMB 5 billion, a year-on-year decrease of 20.28%; net profit attributable to shareholders of the parent company was RMB 932 million, a year-on-year decrease of 27.23%; and basic income per share was 1.05 yuan.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.